NanoViricides, Inc.
NNVC
$1.40
-$0.03-2.10%
AMEX
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -33.22% | 38.69% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -9.09% | 24.29% | |||
| Operating Income | 9.09% | -24.29% | |||
| Income Before Tax | 10.42% | -24.40% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 10.42% | -24.40% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 10.42% | -24.40% | |||
| EBIT | 9.09% | -24.29% | |||
| EBITDA | 9.50% | -26.22% | |||
| EPS Basic | 17.69% | -7.08% | |||
| Normalized Basic EPS | 17.74% | -7.04% | |||
| EPS Diluted | 17.69% | -7.08% | |||
| Normalized Diluted EPS | 17.74% | -7.04% | |||
| Average Basic Shares Outstanding | 8.86% | 16.20% | |||
| Average Diluted Shares Outstanding | 8.86% | 16.20% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||